Hvis du har foretaget ændringer i Pure, vil de snart blive vist her.

Publikationer

Filtrer
Kommentar/debat
2018

Comment on Suissa. Lower risk of death with SGLT2 inhibitors in observational studies: Real or Bias? Diabetes Care 2018;41:6–10

CVD-REAL Investigators and Study Group, jun. 2018, I : Diabetes Care. 41, 6, s. e106-e108

Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

Correction to: Soluble CD163, adiponectin, C-reactive protein and progression of dysglycaemia in individuals at high risk of type 2 diabetes mellitus: the ADDITION-PRO cohort (Diabetologia, 10.1007/s00125-016-4075-4)

Deichgræber, P., Witte, D. R., Møller, H. J., Skriver, M. V., Richelsen, B., Jørgensen, M. E., Johansen, N. B. & Sandbæk, A., feb. 2018, I : Diabetologia. 61, 2, s. 498-503

Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

Publisher Correction: Re-analysis of public genetic data reveals a rare X-chromosomal variant associated with type 2 diabetes

Bonàs-Guarch, S., Guindo-Martínez, M., Miguel-Escalada, I., Grarup, N., Sebastian, D., Rodriguez-Fos, E., Sánchez, F., Planas-Fèlix, M., Cortes-Sánchez, P., González, S., Timshel, P., Pers, T. H., Morgan, C. C., Moran, I., Atla, G., González, J. R., Puiggros, M., Martí, J., Andersson, E. A., Díaz, C. & 23 flere, Badia, R. M., Udler, M., Leong, A., Kaur, V., Flannick, J., Jørgensen, T., Linneberg, A., Jørgensen, M. E., Witte, D. R., Christensen, C., Brandslund, I., Appel, E. V., Scott, R. A., Luan, JA., Langenberg, C., Wareham, N. J., Pedersen, O., Zorzano, A., Florez, J. C., Hansen, T., Ferrer, J., Mercader, J. M. & Torrents, D., 30. maj 2018, I : Nature Communications. 9, 1, 2162.

Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

Åben adgang
Fil
185 Downloads (Pure)

Response by Kosiborod et al to letters regarding article, "lower risk of heart failure and death in patients initiated on sodium-glucose cotransporter-2 inhibitors versus other glucose-lowering drugs: The CVD-REAL study (comparative effectiveness of cardiovascular outcomes in new users of sodium-glucose cotransporter-2 inhibitors)"

Kosiborod, M., Cavender, M. A., Fu, A. Z., Wilding, J. P., Khunti, K., Holl, R. W., Norhammar, A., Birkeland, K. I., Jørgensen, M. E., Thuresson, M., Arya, N., Bodegård, J., Hammar, N. & Fenici, P., 27. feb. 2018, I : Circulation. 137, 9, s. 989-991

Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

Response to Comment on Andersen et al. Risk-Factor Trajectories Preceding Diabetic Polyneuropathy: ADDITION-Denmark. Diabetes Care 2018;41:1955-1962

Andersen, S. T., Witte, D. R., Andersen, H., Bjerg, L., Bruun, N. H., Jørgensen, M. E., Finnerup, N. B., Lauritzen, T., Jensen, T. S., Tankisi, H. & Charles, M., nov. 2018, I : Diabetes Care. 41, 11, s. e148-e149

Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

2017

Reply to Kurtoglu: Association of heart rate variability with diabetes and vitamin D levels

Hansen, C. S., Fleischer, J., Vistisen, D., Ridderstråle, M., Jensen, J. S. & Jørgensen, M. E., 2017, I : Diabetic Medicine. 34, 4, s. 590-591

Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

2016

Response to the Letter: Comment on "Abdominal Fat Distribution and Cardiovascular Risk in Men and Women With Different Levels of Glucose Tolerance" by Scheuer S.H., et al

Scheuer, S. H., Faerch, K., Philipsen, A., Jørgensen, M. E., Johansen, B. N., Carstensen, B., Witte, D. R., Andersen, I., Lauritzen, T. & Andersen, G. S., 2016, I : Journal of Clinical Endocrinology and Metabolism. 101, 2, s. L13-L14

Publikation: Bidrag til tidsskriftKommentar/debatForskning